Wells Fargo maintains 'Underweight' rating on Tesla, citing no stock rebound soon. Tesla's vehicle deliveries are expected to decline in Europe, China, and the US. Earnings may drop 25% by 2025 due to ...

Analyst expectations are far above the prices you'd need to pay now to own a couple of biotechnology stocks. Compass Pathways is developing psilocybin as a treatment for depression. Viking ...

Palantir stock is wildly overvalued even after going through a recent 20% drawdown. Philip Morris International is a growing nicotine business with stable cash cows. Philip Morris generates ...

Procter & Gamble's growth has slowed, with weak cash flow and operational metrics not matching its earnings and sales performance. Despite its defensive profile and dividend history, current valuation ...

The financial media loves to get predictions from experts about where they think a given stock market index is headed. Some experts look at technical analysis patterns, others look at valuation ...

Last week, I highlighted 15 stocks that have created the most shareholder value over the 10-year period from 2015 through 2024, focusing on market appreciation in dollars. This time, I conducted a ...

Investors seeking stocks that can put up dramatic gains in a short amount of time can find what they're looking for in the biotechnology industry. Investment bank analysts on Wall Street have tagged a ...